¥ 427
%E3%80%8A%E5%B8%88%E7%94%9F%E6%83%85%E6%B7%B1%E3%80%8B%E9%AB%98%E6%B8%85%E5%9C%A8%E7%BA%BF%E8%A7%82%E7%9C%8B%E5%AE%8C%E6%95%B4%E5%89%A7%E9%9B%86 江苏荃信生物医药股份有限公司人源化IgG1单克隆抗体QX013N获得临床试验许可用于治疗慢性自发性荨麻疹
¥ 464
¥ 998
¥ 440